The ability of niacin to influence LDL-P is under active investigation and it appears that the beneficial effects of niacin extend beyond the traditional evaluation of the 'lipid profile.' Taken ...

Please provide your email address to receive an email when new articles are posted on . Patients with hyperlipidemia treated with evolocumab had a greater reduction in atherogenic lipoprotein ...

(HealthDay)—Achieving targets of low-density lipoprotein (LDL), as measured by LDL particle number (LDL-P) compared with LDL-cholesterol (LDL-C), is cost-effective, according to a study published in ...

VLDL primarily carries triglycerides for energy use, while LDL mainly transports cholesterol; both are essential for bodily functions but can be potentially harmful in excess. High levels of both VLDL ...

Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on ...

Low-density lipoprotein (LDL) cholesterol, or “bad” cholesterol, collects in the walls of the blood vessels, causing them to narrow. High-density lipoprotein (HDL), or “good” cholesterol, moves LDL ...

Advanced lipid tests can reveal vital information about your cholesterol levels that standard lipid tests can’t. Find out if you should get one. We’ve all heard the standard advice: To reduce high ...

Clin Lipidology. 2009;4(5):565-571. Although the importance of LDL-P and its relation to CAD risk is still being evaluated, there appears overall to be a strong relationship between LDL-P and future ...